Medicine and HealthCell Death and Disease
Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
Y. Hagihara, A. Sakamoto, et al.
Discover the groundbreaking potential of the photoactivatable oncolytic adenovirus (paOAd), engineered by Yasuko Hagihara and team, to revolutionize cancer therapy. This innovative approach harnesses blue light to activate the virus, leading to remarkable tumor growth inhibition without harmful side effects when not triggered. A leap forward in targeting even the most resilient cancer stem cells.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Engineering and Technology
Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges
R. P. Singh, A. Natarajan, et al.
Medicine and Health
Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy
S. Corvigno, Y. Liu, et al.
Medicine and Health
Fully implantable and battery-free wireless optoelectronic system for modulable cancer therapy and real-time monitoring
K. Kim, I. S. Min, et al.
Medicine and Health
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
J. Yi, O. Tavana, et al.
